Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register July 25, 2025. Document 2025-14037. Updated Nov. 21, 2026.
- What it does
The Acting Administrator of the Drug Enforcement Administration (DEA) is issuing this temporary scheduling order to extend the temporary schedule I status of five designer benzodiazepines--clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam. In an order dated July 26, 2023, DEA temporarily placed these five substances in schedule I of the Controlled Substances Act. This temporary order will extend the temporary scheduling of five designer benzodiazepines for one year, or until the permanent scheduling action for these substances is completed, whichever occurs first. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will continue to be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these five specified controlled substances.
The Drug Enforcement Administration's summary, as published in the Federal Register.
- What changed in the regulation
1 part of Title 21 of the Code of Federal Regulations:
Wording on eCFR: the day before it took effect and from the day it took effect (first part listed).
- Compared with
The Drug Enforcement Administration has published 27 final rules in 2026 so far, compared with 17 in all of 2025.
Counted by the Tribune from Federal Register records since Jan. 1, 2025.
- What happens next and when
This temporary scheduling order, which extends schedule I control of five specific substances covered by an order (88 FR 48112, July 26, 2023), is effective July 26, 2025, and expires on July 26, 2026. If DEA publishes a final rule making this scheduling action permanent, this order will expire on the effective date of that rule, if the effective date is earlier than July 26, 2026.
The agency's dates, word for word.
The record as published
| Document number | 2025-14037 |
|---|---|
| Action | Temporary scheduling order; extension. |
| Agencies | Justice Department; Drug Enforcement Administration |
| Published | July 25, 2025 |
| Effective date | July 26, 2025 |
| Docket | DEA-2022-0145 |
Source: the Federal Register (public domain). The document in the Federal Register